Current evidence for closure of a patent foramen ovale for cryptogenic stroke prevention

E Rhone1, N Chung, B Clapp

  • 1Kings College London Medical School, London, UK.

Insights

Patent foramen ovale closure may be a viable option for cryptogenic stroke prevention. This review examines recent trials comparing PFO closure to medical therapy for secondary stroke prevention.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • Patent foramen ovale (PFO) is associated with cryptogenic stroke (CS), a significant cause of ischemic stroke.
  • The efficacy of PFO closure versus medical therapy for secondary stroke prevention remains under investigation.

Purpose of the Study:

  • To review and compare evidence on percutaneous PFO closure against medical therapy for secondary stroke prevention.
  • To analyze recent randomized controlled trials (RCTs) in this field.

Main Methods:

  • Literature review focusing on comparative studies of PFO closure and medical therapy.
  • Analysis of three recent randomized controlled trials (RCTs).

Main Results:

  • Evidence comparing PFO closure to medical therapy for secondary stroke prevention is still evolving.
  • Recent RCTs provide critical data for evaluating treatment strategies.

Conclusions:

  • Further research and analysis of RCTs are necessary to determine the optimal secondary prevention strategy for patients with PFO and CS.
  • The role of PFO closure in stroke prevention requires continued evaluation in light of new evidence.

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
30
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
44